Introduction
Bacteria with recombinant proteins displayed on their surface have numerous biotechnological applications. They can act as bioadsorbents, biosensors, biocatalysts or oral vaccines. In addition, bacterial surface display can be exploited in antibody production, screening of peptide libraries and detection of mutations (Georgiou et al., 1997; Stahl and Uhlen, 1997; Lee et al., 2003) . For surface display, the protein to be displayed ( passenger protein) is fused to an anchoring motif (carrier protein) (Georgiou et al., 1997; Stahl and Uhlen, 1997; Lee et al., 2003) . Surface display systems have been developed for Gram-negative bacteria (Georgiou et al., 1997) , for Grampositive bacteria (Stahl and Uhlen, 1997) and for yeasts (Ueda and Tanaka, 2000) .
Lactic acid bacteria (LAB) are important hosts in biotechnology due to their safety, industrial applicability and beneficial influence on health. Several strains of different species have been used in therapy as probiotics (de Vrese and Schrezenmeir, 2008) . Surface display on LAB has been used mainly for antigens, to prepare mucosal vaccines (Wells, 2011; Bahey-El-Din, 2012; Berlec et al., 2013) . In addition, surface display has been used to display binding molecules directed against pro-inflammatory molecules such as tumor necrosis factor-a in inflammatory bowel disease (Ravnikar et al., 2010) , for the assembly of macromolecular enzyme complexes (Wieczorek and Martin, 2010) and for immobilization of bacterial cells (Liu et al., 2011) . Five different types of surface anchoring domains have been described for LAB, including transmembrane domains, lipoprotein anchor domains, LPXTG-type domains, lysin motif (LysM) domains and surface layer proteins (Leenhouts et al., 1999) . In the prototype LAB, Lactococcus lactis, the most frequently applied surface anchoring domains are the LPXTG sequence of the M6 protein of Streptococcus pyrogenes (Dieye et al., 2001; Ribeiro et al., 2002; Wieczorek and Martin, 2010) , and the C-terminal part of endogenous AcmA that contains the peptidoglycan-binding LysM repeats (Ramasamy et al., 2006; Okano et al., 2008; Lim et al., 2010; Ravnikar et al., 2010) . However, new surface display approaches are still being sought. In our previous study of the lactococcal surface proteome, we identified the basic membrane protein A (BmpA) as a promising carrier for surface display in L.lactis (Berlec et al., 2011) .
BmpA is a lipoprotein that contains the characteristic lipobox in the N-terminal signal peptide that is cleaved by signal peptidase II in the process of covalent anchoring of the protein to the membrane lipid bilayer (Desvaux et al., 2006) . BmpA is a solute-binding subunit of the classical ABC transporter (Eitinger et al., 2011) that is responsible for the import of purines (Martinussen et al., 2010) . The sequence of lactococcal BmpA molecule shows 31% identity to that of the BmpA from Borrelia burgdorferi, which is an immunodominant protein (Roessler et al., 1997) with laminin-binding ability (Verma et al., 2009) .
In this study, we optimized BmpA-based surface display of IgG-binding B domain of staphylococcal protein A (Ravnikar et al., 2010) . The B domain can be detected directly with specific antibodies against protein A, or indirectly, with any antibody whose Fc region can be bound by the B domain. It can be used to demonstrate both the location and the functionality of the passenger protein, and can serve as affibody prototype (Nygren, 2008) . We minimized the relatively bulky BmpA molecule that could limit the translocation of larger fusion proteins. A truncated variant of BmpA without spacer, termed Bmp1, exhibited markedly increased ability for surface display.
Materials and methods

BmpA modeling
The secondary structure of the BmpA was predicted with Phyre server (http://www.sbg.bio.ic.ac.uk/~phyre) (Kelley and Sternberg, 2009) and the tertiary structure with I-Tasser (http:// zhanglab.ccmb.med.umich.edu/I-TASSER) . Images were prepared with PyMOL (http://www.pymol.org).
Bacterial strains, media and culture conditions
The bacterial strains used in this study are listed in Supplementary Table SI. Lactococcus lactis NZ9000 was grown in M-17 medium (Merck) supplemented with 0.5% glucose (GM-17) and 10 mg/ml of chloramphenicol at 308C, without aeration. Escherichia coli strain DH5a was grown at 378C with aeration in Luria -Bertani medium supplemented with 100 mg/ml ampicillin.
Cloning procedures, mutagenesis and expression of the BmpA variants in L.lactis Cloning procedures, mutagenesis and expression of the BmpA variants are described in the Supplementary materials.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blots
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described in the Supplementary materials.
Adhesion to Caco-2 cells
The Caco-2 human colon adenocarcinoma cell line was cultured in Dulbecco's modified Eagle's medium (SigmaAldrich) with L-glutamine, 10% fetal calf serum (HyClone) and 50 mg/ml of gentamycin sulfate (Sigma-Aldrich) at 378C in 10% CO 2 . To assay adhesion, the cells were seeded at a concentration of 10 4 cells per well in 24-well tissue culture plates and cultured for ca. 3 weeks to form a monolayer.
Cultures of L.lactis expressing BmpA, or containing an empty plasmid (control), were washed once with phosphatebuffered saline (PBS), diluted to OD 600 ¼ 0.50 and enumerated by plate counting on GM-17 plates. One milliliter of cell suspension was added to each well with a Caco-2 monolayer previously washed twice with PBS, and incubated for 30 min. Unattached bacteria were removed by triple washing with PBS. Caco-2 cells were lyzed with 0.05% Triton X-100 (Sigma-Aldrich) for 5 min, and adherent lactococci enumerated by plate counting on GM-17 plates. Lactococcal cultures were prepared in duplicate and each incubated with Caco-2 monolayer in 10 repeats. The proportions of adherent bacteria were calculated and averaged.
Flow cytometry and fluorescence microscopy
Ten microliters of cell culture (2 Â 10 9 cells/ml) were added to 500 ml of tris-buffered saline (TBS) (50 mM Tris -HCl, 150 mM NaCl and pH 7.5) and centrifuged for 3 min at 5000 Âg at 48C. Pellets were resuspended in 500 ml of TBS containing fluorescein isothiocyanate conjugated anti-protein A antibody (Abcam) or Alexa Fluor 488 conjugated rabbit anti-mouse antibody (Abcam) diluted 1 : 500 and incubated for 2 h at room temperature (RT) with constant shaking at 100 rpm. The cells were then washed three times with 200 ml 0.1% TBST and resuspended in 500 ml of TBS. The stained cells were analyzed by flow cytometry (FACS Calibur; Becton Dickinson) by using 488 nm excitation and 530 nm emission in the FL1 channel. Geometric mean fluorescence intensity (MFI) of at least 20 000 bacterial cells was measured. The average of three independent experiments was considered.
The staining protocol for the fluorescence microscopy was similar, except that the starting volume of the cell cultures was 20 ml and the final volume of the TBS for resuspension was 300 ml. Fluorescence microscopy was performed by using a Carl Zeiss LSM 710 confocal microscope. Alexa Fluor 488 was excited with an argon laser (488 nm), and the emission was filtered by using a narrow-band 505-530 nm filter.
Purification of the Bmp1 cleavage fragments
Bmp1 with hexa-histidine fusion was expressed in 100 ml culture as described above. The soluble fraction of the cell lysate was loaded on 0.8 ml of BD Talon metal affinity resin (BD Biosciences) according to the manufacturer's instructions, by using batch/gravity-flow column purification and imidazole elution.
N-terminal sequencing
Purified Bmp1 was loaded on SDS-PAGE and blotted to polyvinylidene difluoride membrane. The membrane was stained briefly with Coomassie Brilliant Blue and dried; appropriate bands were excised. The N-terminal amino acid sequences were determined by automated Edman degradation by using an Applied Biosystems 492 Protein sequencer.
Results
Adhesion of BmpA-expressing lactococci to the Caco-2 monolayer
Expression and surface display of the BmpA significantly (P , 0.005) increased the ability of the lactococci to adhere to the Caco-2 cell monolayer, a model of intestinal epithelium. After stringent washing, the number of adhered bacteria was increased by 1.3-fold relative to the control (Fig. 1) . 
Design of the BmpA variants
Truncated variants of the BmpA were designed on the basis of the secondary structure prediction (Supplementary Fig. S1 ). The N-terminus was preserved in all of the variants. C-termini were defined in the loops between the a-helices and the b-sheets, where possible, following the Ser or the Gly residues ( Supplementary Fig. S1 ). A spacer (SGGGG) 3 was introduced between the BmpA variants and the passenger protein (B domain) to increase their mutual distance. All of the variants are shown schematically in Fig. 2 .
Expression of the BmpA variants
The BmpA variants fused with the B domain were expressed by using nisin-controlled expression (Mierau and Kleerebezem, 2005) . Lysates of the cells expressing BmpA were compared with those of the negative control cells containing empty plasmid, and positive control cells containing pSDLBA3b. All of the BmpA variants in fusion with the B domain were detected on the western blots or on both of the western blots and the Coomassie-stained gels ( Supplementary Fig. S2) ; however, the expression levels of the variants were significantly different. The molecular weights of the proteins corresponded to those calculated (Supplementary Table SII) . Specific proteolytic cleavage products were observed with Bmp1-4 ( Supplementary Fig. S2 ). The B domain-containing cleavage products had molecular weights ca. 15 kDa lower than those of the parent proteins.
Evaluation of the BmpA variants as potential carrier proteins
The ability of the BmpA variants to display the B domain on the surface of the lactococci was analyzed by flow cytometry and fluorescence microscopy. MFI was measured for all of the variants and was normalized relative to the MFI of the negative control (Fig. 3) . Similar results were obtained with both antibodies used (anti-protein A, specific for the B domain (Fig. 3A) ; anti-mouse, unspecific for the B domain and bound via the Fc region (Fig. 3B) ). Of the BmpA variants, Bmp1 increased surface display to the greatest extent. Compared with BmpA, the display was increased by ca. 3.3-fold or 5.6-fold, as determined with the use of specific or unspecific antibodies, respectively. Also, variants Bmp2 and Bmp3, with or without the spacer, as well as Bmp1 with the spacer, demonstrated a greater ability than BmpA to display the B domain on the lactococcal surface; however, the display was lower than that with Bmp1. Spacer (SGGGG) 3 did not increase the surface display of the BmpA variants since, in general, the variants without the spacer performed better than their counterparts with the spacer (Fig. 3) . Bmp1-mediated surface display of the B domain was lower than the previously described LysM repeats (AcmA)-mediated surface display (Ramasamy et al., 2006; Okano et al., 2008; Lim et al., 2010; Ravnikar et al., 2010) by ca. 3.6-fold or 4.4-fold (as determined with the use of specific or unspecific antibodies, respectively).
BmpA-, Bmp1-and AcmA-mediated surface display of the B domain was also evaluated with fluorescence microscopy and compared with the control cells. The results corresponded well with those of the flow cytometry. Cells with Bmp1-displayed B domain had much stronger fluorescence than cells with BmpA-displayed B domain; the fluorescence, however, was even stronger with AcmA-mediated display (Fig. 4) .
Modeling of the BmpA and the Bmp1 structure 
Susceptibility of Bmp1 to the proteolytic cleavage
In contrast to BmpA, its variants Bmp1 -4 were observed to be prone to relatively specific proteolytic degradation ( Supplementary Fig. S2 ), resulting in a residue 15 kDa smaller. This was detected by a specific antibody and therefore contained the B domain, indicating the removal of the N-terminal part of the protein. Since this could affect the surface display ability of Bmp1 -4, we determined the N-terminal sequence of the Bmp1 cleavage product. Supplementary Fig. S3 ). Engineering BmpA for surface display
Discussion
Our previous study established BmpA as a candidate carrier protein for surface display on L.lactis (Berlec et al., 2011) . In comparison with the non-covalent surface attachment mediated by the LysM domains, BmpA enables covalent, lipoprotein signal-based surface binding, which may be advantageous for applications that require stronger binding (Berlec et al., 2011) . In the present study, we aimed at improving its B domain surface display ability by testing BmpA intestinal adhesion properties and by engineering and minimizing the BmpA molecule.
Since BmpA from B.burgdorferi has a laminin adhesion property (Verma et al., 2009) , we tested whether overexpression of lactococcal BmpA could influence the adhesion of the bacteria to the intestinal epithelium in comparison with the basal expression of BmpA. A modest increase in binding to the epithelial model, the Caco-2 monolayer, was indeed observed with BmpA overexpression.
The BmpA molecule was truncated at its C-terminus at sites corresponding to the predicted loops between the a-helices and the b-sheets. Nine variants were produced in an attempt to reduce the size of the carrier protein, thereby contributing to the smaller size of the fusion protein and potentially improving the translocation efficiency and the surface display. In addition, (SGGGG) 3 spacer was introduced to all of the variants between the carrier and the passenger to increase their distance apart, to avoid steric hindrance and to move the passenger away from the bacterial surface.
All of the BmpA variants were expressed, as observed from the results of Coomassie staining and western blot; however, the truncation of the BmpA molecule affected the protein expression level. The total expression level of the fusion protein (determined by western blot) was not studied in greater detail, because it does not necessarily correspond to the level of the surface displayed protein. Not all of the expressed protein is translocated to the bacterial surface, and not all of the translocated protein has favorable spatial orientation of the passenger protein. Flow cytometry was used to determine the amount of the surface-bound antibody, which corresponds to the amount of the surface displayed B domain. Flow cytometry may therefore be regarded as the most relevant measure of the surface display efficiency, while total fusion protein expression may be regarded only as one of the indicators of the latter.
The BmpA variant termed Bmp1, which lacked 44 amino acids at its C-terminal, increased the surface display ability over that of the BmpA for several folds; however, the surface display ability was still inferior to that of the peptidoglycanbinding domain of the AcmA. Bmp2 and Bmp3 also increased the surface display ability over that of BmpA, but to a lesser extent than Bmp1. Further stepwise shortening of the molecule resulted in the stepwise decrease or abolition of the surface display ability, indicating the importance of the bulk of the molecule in the surface display. This indicates that the lipoprotein signal peptide is by itself not sufficient for considerable translocation or surface exposure of the passenger protein.
Comparison of the variants with and without the spacer showed that the introduction of the spacer had little or no effect on the surface display ability. It is possible that the flexibility, introduced by the spacer, hinders efficient interaction with the antibodies. This also indicates that direct fusion of the carrier and the passenger is not a limiting factor in the surface display with the BmpA or its variants. To summarize, Bmp1 without the spacer qualifies as a new carrier in the lactococcal surface display of functional proteins. The large improvement of Bmp1-over BmpA-mediated surface display was also confirmed with fluorescent microscopy.
Comparison of BmpA with Bmp1 was therefore studied further by modeling both of the structures. The models suggest that both of the proteins are composed of two a/b domains with an intermediate substrate binding cleft, probably for the purines. Their C-termini (the sites of the passenger protein fusion) are located on opposite domains; the C-terminus of Bmp1 is therefore predicted to be closer to the N-terminus than the C-terminus of BmpA. This is contrary to our initial assumption that the increase in the distance of the passenger protein from the membrane (N-terminus) is the most important factor in increasing the surface display ability. Our assumption is further refuted by the fact that the introduction of the (SGGGG) 3 spacer does not increase the ability for the surface display. The model does not offer more specific reasons for increased surface display with Bmp1. Removal of part of the second domain in Bmp1 may have resulted in removal of the steric hindrance. It is also possible that the passenger protein modifies the position of the N-terminus, particularly with Bmp1, yielding an orientation more favorable for the surface display; however, Engineering BmpA for surface display the modeling of the fusion protein provided no consistent results and is thus not shown.
Another difference between BmpA and Bmp1 is the greater susceptibility of the latter to the relatively specific proteolytic digestion, as seen by the appearance of a band of lower molecular weight (ca. 15 kDa) on the SDS -PAGE gel. A similar result was observed with the variants Bmp2-4 and can probably be attributed to the exposure of the amino acid residues normally buried in BmpA. Asp 131 was established at the cleavage site in Bmp1. An increase in the surface display could be envisaged if the degradation of the carrier protein were prevented. However, changing the Asp to the chemically related Asn and Glu did not prevent degradation; it even resulted in a small decrease of the surface display. This indicates the lower specificity of the protease(s) involved, and suggests a broader mutagenesis approach in order to prevent the cleavage.
To summarize, 18 variants of BmpA were investigated for their B domain surface display ability. Substantial minimization of the BmpA molecule abolished its surface display ability; however, the removal of the smaller part of the molecule (variant Bmp1) resulted in significantly increased surface display ability of the B domain in comparison with BmpA. Bmp1 has therefore been selected as an optimized carrier protein for the surface display of the B domain in L.lactis. Although the display with Bmp1 is inferior to that achieved with the peptidoglycan-binding domain of the AcmA, it enables stronger covalent surface attachment (in comparison with the non-covalent binding of the AcmA) and therefore represents an attractive alternative to the established surface display approaches. In addition, BmpA-mediated increase in epithelial cell adhesion could lead to increased intestinal retention of the bacteria. This will be further assessed with Bmp1 in an animal model, with a final goal of establishing a novel LAB-based intestinal delivery system.
Supplementary data
Supplementary data are available at PEDS online.
